Understanding a drug’s mechanism of action (MOA) can greatly increase the likelihood of successful clinical trials by identifying biomarkers of patient response and providing a rationale for ...

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for patients with ...

Preservatives inhibit or kill microorganisms, preventing spoilage and extending the shelf life of cosmetics. Ideally, preservatives should be effective against a wide range of microorganisms, soluble ...

The last time I spoke about Tourmaline Bio, Inc. (TRML), it was with respect to a Seeking Alpha article entitled "Tourmaline Bio: TRANQUILITY Study Data Lends Credibility For IL-6 Inhibition." With ...

Panelists discuss how the muscarinic pathway of xanomeline/trospium offers a safer, nondopaminergic approach to schizophrenia care. Panelists discuss how xanomeline/trospium chloride introduces a ...

Merus N.V., an oncology-focused company, announced the publication of research on petosemtamab, a bispecific antibody targeting EGFR and LGR5, in the journal "Cancers." The study highlights the ...

The rise of antimicrobial-resistant pathogens has spurred scientists to search far and wide for new drugs. And while many antimicrobial molecules have been discovered in recent years, it’s rare to ...

However, investigating such modes of action for a whole compound library would have been very resource-intensive in the past. Researchers at the Department of Biomedicine at the University of Basel ...

The first contraceptive pill available for human use in 1960 contained the estrogen mestranol, an ethinyl-estradiol precursor, in a very high concentration (150 mg), and norethynodrel, a ...